Marius Reto Bigler Profile
Marius Reto Bigler

@biglermarius

Followers
36
Following
121
Media
7
Statuses
54

Research fellow in coronary (patho-)physiology and interventional cardiology

Bern, Schweiz
Joined June 2020
Don't wanna be here? Send us removal request.
@DaryoushSamim
Daryoush Samim
7 months
Double Transcatheter AV Replacement: •A staged transcatheter Tx offers a promising strategy for surgical high risk patients with multi valvular heart disease (VHD) •Further evidence from RCT is needed for the transcatheter Tx of multi VHD https://t.co/D5CJRdzh5p
1
2
8
@CircAHA
Circulation
8 months
Among patients with an anomalous aortic origin of the right coronary artery, coronary artery CT can be used to safely risk stratify individuals @chrisgraeni @inselgruppe @BernCVRC @13Kakiz @yasushiueki @biglermarius @Fbiccire @isaacshiri @chrisgraeni https://t.co/50QNuA5lZA
1
11
23
@DaryoushSamim
Daryoush Samim
11 months
Echo screening of TB patients facilitates early detection of CV involvement. Routine echo at baseline in all newly diagnosed TB patients may allow for timely medical management and prevent complications such as constriction and heart failure. @JACCJournals https://t.co/Eafx6yW8kd
0
5
12
@BernCVRC
Cardiovascular Research Cluster (CVRC)
1 year
New publication: “Intracoronary ECG ST-Segment Shift Remission Time During Reactive Myocardial Hyperemia (Τ-icECG): A New Method to Assess Hemodynamic Coronary Stenosis Severity ”. Congratulations to the authors! https://t.co/0IzxaUOrbA @biglermarius #BernCVRC
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Fractional flow reserve (FFR) measurements are recommended for assessing hemodynamic coronary stenosis severity. Intracoronary ECG (icECG) is easily obtainable and highly sensitive in detecting...
2
1
1
@chrisgraeni
Christoph Gräni
1 year
@JAMA_current
JAMA
1 year
Meta-analysis examined the value of cardiac MRI–derived measurements for risk stratification in patients with nonischemic dilated cardiomyopathy. The presence and extent of late gadolinium enhancement were associated with adverse clinical outcomes. https://t.co/mtsUjkoLv6
0
3
7
@BernCVRC
Cardiovascular Research Cluster (CVRC)
1 year
New publication: “Clinical Efficacy of Permanent Internal Mammary Artery Occlusion in Chronic Coronary Syndrome: A Double-Blind, Randomized, Sham-Controlled Trial”. Congratulations to the authors! https://t.co/keYkuTCBti @biglermarius #BernCVRC
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
The Clinical Efficacy of Permanent Internal Mammary Artery Occlusion in Chronic Coronary Syndrome (CLIMACCS) trial, a randomized, sham-controlled trial, tested the clinical efficacy of permanent...
0
1
2
@chrisgraeni
Christoph Gräni
1 year
🚨 Rethink #Anomalous Aortic Origin of Coronary Artery #AAOCA + #interarterial course. 🚫No 'scissor-like' compression (unidirectional intramural compression by the aorta) 🚫Not all ‚malignant‘ (relevant) @RaberLorenz @biglermarius @snsf_ch @EHJCREiC https://t.co/gm9kePQjPx
1
7
13
@BernCVRC
Cardiovascular Research Cluster (CVRC)
2 years
New publication: “Noninvasive Multimodality Imaging for the Assessment of Anomalous Coronary Artery”. Congratulations to the authors! https://t.co/Qnw6zz1e1L @chrisgraeni #BernCVRC
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
The assessment of AAOCA includes an accurate description of the anomalous origin/vessel course including anatomical high-risk features such as a slit-like ostium, proximal narrowing, elliptic vessel...
0
1
2
@BabkenAsatryan
Babken Asatryan, MD, PhD
2 years
I am so glad to see our latest work on Genotype-First Look at Cardiomyopathy-Related Outcomes published in #JACCHF. Thanks #GenotypeFirstInvestigators for your help and support! @JACCJournals @AnwarChahal @APLandstrom @CSHeartResearch https://t.co/kuVyjaCTze
0
12
31
@RaberLorenz
Lorenz Räber, MD PhD
2 years
#ESC #fasttrack Concomitant Coronary Atheroma Regression&Stabilization in Response to Lipid-Lowering Therapy | JACC https://t.co/HR3eocB70a Congratulations to @FBiccire for his presentation @escardio and simultaneous publication in @JACCJournals @PCRonline @BernCVRC @unibern
0
13
36
@chrisgraeni
Christoph Gräni
2 years
📢 NEW study #whyCMR in #myocarditis : 🔎In 659 Pat. RV GLS linked to MACE, HF & 🪦in univariable, but not multivariable 📊. ⁉️RV GLS can be used as an easy and fast 🛠️but is maybe not better than RVEF and other CMR parameters in myocarditis🙌 @SCMRorg https://t.co/PMDbTYeWeT
0
2
13
@MedFacultyUniBE
Faculty of Medicine, University of Bern
2 years
Two Investigator Initiated Clinical Trial Grants from @snf_ch for the Medical Faculty of @unibern. 🥂Congratulations to @retoauer, @RaberLorenz, and @DavidSeiffge for this big success. Here is a summary of their projects addressing important unmet needs: https://t.co/8zFGeRB0NL
4
19
39
@BernCVRC
Cardiovascular Research Cluster (CVRC)
3 years
Fokus Herz Bern 2023 is here! Come and gain insight into the latest cardiovascular research. For more info go to: https://t.co/EfJVzes19N #BernCVRC #fokusherzbern
0
2
5
@DBMR_UniBe
BioMedical Research
3 years
Congratulations to our researchers, who are once again among the most cited in the world. https://t.co/r2C9wP19ik #highlycited2022 @ClarivateAG @unibern @MarkARubin1 @PMBern @inselgruppe
0
3
4
@chrisgraeni
Christoph Gräni
3 years
0
8
19
@chrisgraeni
Christoph Gräni
3 years
💥 Published today #JACCimg 👉🏼 Right ventricle is another🔑 in #myocarditis: ❗️26% have RV involvement in 🧲#whyCMR ‼️RVEF is an independent and incremental predictor of ☠️ 🏥(beyond clinics, LVEF and LV LGE-extent). @domcbenz @BernCVRC @JACCjournals https://t.co/dpoHomQsSo
0
10
19
@JAHA_AHA
JAHA
3 years
State-of-the-art review: Management of anomalous coronary arteries #ACAOS. Evidence, Proposed Approach and the Unknowing #AHAJournals #CardioTwitter @biglermarius @MatthiasSiepe @RaberLorenz @MassimoPadalin3 #AHAJournals
0
3
3
@drdavemd
David Winchester @drdavemd.bsky.social
3 years
As a fellow, Dr. James Hill used to tell us that we were restricted to presenting one anomalous coronary case per year in conference, because they are just not that rare. Then, and now, the management of anom cors is often unclear @biglermarius
ahajournals.org
1
2
5
@chrisgraeni
Christoph Gräni
3 years
Hot off the press🔥: happy to share our review in @JAHA_AHA highlighting the management of #ACAOS #AAOCA considering pathophysiology and hemodynamics. @biglermarius @MassimoPadalin3 @MatthiasSiepe @RaberLorenz https://t.co/25hRZlj9wR
0
9
20